Med-Chemist : "Quintessential Medicinal Chemistry"
Wednesday, May 18, 2011
New insect repellant may be thousands of times stronger than DEET
›
In continuation of mosquito repellants and DEET Researchers report the identification and characterization of an Orc...
Tuesday, May 17, 2011
Novel two-drug combination cures young patient with extensively drug-resistant tuberculosis
›
The combination of meropenem (above structure) with clavulanate (right structure-potassium salt) has high antimycobacte...
4 comments:
Monday, May 16, 2011
Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS
›
We know the recent development about 'FAMPYRA' by " European Medicines Agency"..... Australian TGA approves Biog...
First EffRx NDA accepted for filing by the FDA...
›
EffRx Pharmaceuticals SA , an Epalinges/Lausanne, Switzerland based drug delivery company announces that the New Drug Application (ND...
1 comment:
Sunday, May 15, 2011
Regenerating nerve cells: Research offers hope in new treatment for spinal cord injuries
›
Regenerating nerve cells: Research offers hope in new treatment for spinal cord injuries
Saturday, May 14, 2011
Clinical study: Celecoxib drug may treat breast cancer
›
In continuation of m update on Celecoxib Clinical study: Celecoxib drug may treat breast cancer
Wednesday, May 11, 2011
World's first urine-based tuberculosis diagnostics tool
›
World's first urine-based tuberculosis diagnostics tool
Monday, May 9, 2011
Temsirolimus with chemotherapy may serve as promising therapy for mesothelioma
›
We know that Temsirolimus (CCI-779) is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharm...
Pfizer RA Drug Meets Study Goals
›
We knew that, Tofacitinib (see structure, formerly tasocitinib is a drug being investigated by Pfizer for the treatment of rheuma...
Sunday, May 8, 2011
New research shows honey fights drug-resistant germs
›
In continuation of my update on antibacterial activity of honey.... New research shows honey fights drug-resistant germs
Friday, May 6, 2011
Scientists develop new compound for multiple sclerosis treatment
›
Scientists from the Florida campus of The Scripps Research Institute have developed the first of a new class of highly selective compound...
Thursday, May 5, 2011
FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors....
›
In continuation of my update on sutent/sunitib .... Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor "...
Wednesday, May 4, 2011
FDA approves new targeted therapy to treat men with advanced prostate cancer..
›
In continuation of my update on Abiraterone ... . We know that, Abiraterone (tradename Zytiga) is a drug currently under investig...
Tuesday, May 3, 2011
Ohio State biophysicist disrupts cellular messages through fragment-based drug design
›
In continuation of my update on FBDD .. Ohio State biophysicist disrupts cellular messages through fragment-based drug design
Sunday, May 1, 2011
Maxwell Biotech, Sequella enter license agreement to commercialize SQ109 for TB treatment
›
In continuation of my update on drug discovery on TB ... Maxwell Biotech, Sequella enter license agreement to commercialize SQ109 fo...
‹
›
Home
View web version